These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2779414)

  • 1. A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA.
    Grant CW; Karlik S; Florio E
    Magn Reson Med; 1989 Aug; 11(2):236-43. PubMed ID: 2779414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of two membrane-based liposomal MRI contrast agents.
    Karlik S; Florio E; Grant CW
    Magn Reson Med; 1991 May; 19(1):56-66. PubMed ID: 2046538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Holmberg E; Maruyama K; Huang L
    Magn Reson Imaging; 1991; 9(3):373-7. PubMed ID: 1881256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced biliary iron excretion with amphiphilic diethylenetriaminepentaacetic acid.
    Adams PC; Lin E; Barber KR; Grant CW
    Hepatology; 1991 Dec; 14(6):1230-4. PubMed ID: 1959873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
    Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
    Tilcock C; Unger E; Cullis P; MacDougall P
    Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates.
    Tilcock C; Ahkong QF; Koenig SH; Brown RD; Davis M; Kabalka G
    Magn Reson Med; 1992 Sep; 27(1):44-51. PubMed ID: 1435209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three remote radiolabelling methods for long-circulating liposomes.
    van der Geest T; Laverman P; Gerrits D; Franssen GM; Metselaar JM; Storm G; Boerman OC
    J Control Release; 2015 Dec; 220(Pt A):239-244. PubMed ID: 26514291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline consideration of liposomal contrast agent. CNS transport by macrophages in experimental allergic encephalomyelitis.
    Stavraky RT; Grant CW; Barber KR; Karlik SJ
    Magn Reson Imaging; 1993; 11(5):685-9. PubMed ID: 8345783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phospholipid spin label used as a liposome-associated MRI contrast agent.
    Grant CW; Barber KR; Florio E; Karlik S
    Magn Reson Med; 1987 Oct; 5(4):371-6. PubMed ID: 3683167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.
    Schwendener RA; Wüthrich R; Duewell S; Wehrli E; von Schulthess GK
    Invest Radiol; 1990 Aug; 25(8):922-32. PubMed ID: 2394576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
    Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
    Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements.
    de Vries A; Kok MB; Sanders HM; Nicolay K; Strijkers GJ; Grüll H
    Contrast Media Mol Imaging; 2012; 7(1):68-75. PubMed ID: 22344882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.